Human Heart Morphogenesis: A New Vision Based on In Vivo Labeling and Cell Tracking.
Laura Villavicencio-GuzmánConcepción Sánchez-GómezRicardo Jaime-CruzTania Cristina Ramírez-FuentesCarlos César Patiño-MoralesMarcela Salazar-GarcíaPublished in: Life (Basel, Switzerland) (2023)
Despite the extensive information available on the different genetic, epigenetic, and molecular features of cardiogenesis, the origin of congenital heart defects remains unknown. Most genetic and molecular studies have been conducted outside the context of the progressive anatomical and histological changes in the embryonic heart, which is one of the reasons for the limited knowledge of the origins of congenital heart diseases. We integrated the findings of descriptive studies on human embryos and experimental studies on chick, rat, and mouse embryos. This research is based on the new dynamic concept of heart development and the existence of two heart fields. The first field corresponds to the straight heart tube, into which splanchnic mesodermal cells from the second heart field are gradually recruited. The overall aim was to create a new vision for the analysis, diagnosis, and regionalized classification of congenital defects of the heart and great arteries. In addition to highlighting the importance of genetic factors in the development of congenital heart disease, this study provides new insights into the composition of the straight heart tube, the processes of twisting and folding, and the fate of the conus in the development of the right ventricle and its outflow tract. The new vision, based on in vivo labeling and cell tracking and enhanced by models such as gastruloids and organoids, has contributed to a better understanding of important errors in cardiac morphogenesis, which may lead to several congenital heart diseases.
Keyphrases
- heart failure
- atrial fibrillation
- congenital heart disease
- endothelial cells
- healthcare
- emergency department
- genome wide
- dna methylation
- machine learning
- coronary artery
- bone marrow
- single molecule
- cell therapy
- left ventricular
- patient safety
- mesenchymal stem cells
- pulmonary hypertension
- cross sectional
- copy number
- case control
- social media
- molecular dynamics simulations
- quality improvement